Tuesday, September 15, 2020

Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India

Drugs Controller General of India Dr VG Somani gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country.

from NDTV News - Latest https://ift.tt/2Rxkbqa
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Women Gig Workers Lead Nationwide Protest, Demand Fair Wages, Social Security

Thousands of gig and platform service workers, led largely by women, staged a nationwide protest on Tuesday against what they described as w...